Galaxy Medicare Limited (NSE:GML)
18.40
0.00 (0.00%)
At close: Feb 18, 2026
Galaxy Medicare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 406.97 | 392.02 | 361.51 | 312.05 | 298.78 | 287.27 |
Other Revenue | 0.5 | 0.5 | 1.13 | 0.25 | 0.61 | 0.78 |
| 407.47 | 392.52 | 362.63 | 312.31 | 299.38 | 288.05 | |
Revenue Growth (YoY) | - | 8.24% | 16.11% | 4.32% | 3.93% | 8.16% |
Cost of Revenue | 259.86 | 256.15 | 227.34 | 215.83 | 209.77 | 207.57 |
Gross Profit | 147.61 | 136.37 | 135.3 | 96.48 | 89.61 | 80.49 |
Selling, General & Admin | 51.11 | 46.17 | 38.98 | 32.46 | 28.72 | 25.97 |
Other Operating Expenses | 41.36 | 36.52 | 39.87 | 35.02 | 31.12 | 26.42 |
Operating Expenses | 97.95 | 87.68 | 83.66 | 78.64 | 69.67 | 61.96 |
Operating Income | 49.65 | 48.69 | 51.63 | 17.84 | 19.95 | 18.53 |
Interest Expense | -4.11 | -6.72 | -9.38 | -8.83 | -7.97 | -7.22 |
Interest & Investment Income | 1.94 | 1.94 | 0.61 | 1.39 | 0.24 | 0.23 |
Currency Exchange Gain (Loss) | 0.9 | 0.9 | 0.53 | 0.78 | 0.65 | 0.14 |
Other Non Operating Income (Expenses) | -0.68 | -0.68 | -0.03 | -0.68 | -0.87 | -0.74 |
EBT Excluding Unusual Items | 47.7 | 44.13 | 43.36 | 10.49 | 11.99 | 10.94 |
Gain (Loss) on Sale of Investments | 1.13 | 1.13 | 3.9 | 9.54 | -11.62 | 0.29 |
Gain (Loss) on Sale of Assets | - | - | - | -0.55 | -0.05 | -0.82 |
Other Unusual Items | 0.08 | 0.08 | - | 0.55 | 0.41 | - |
Pretax Income | 48.91 | 45.34 | 47.26 | 20.03 | 0.74 | 10.41 |
Income Tax Expense | 12.1 | 11.63 | 10.19 | 4.31 | 2.87 | 3.24 |
Net Income | 36.8 | 33.7 | 37.07 | 15.71 | -2.13 | 7.18 |
Net Income to Common | 36.8 | 33.7 | 37.07 | 15.71 | -2.13 | 7.18 |
Net Income Growth | - | -9.09% | 135.93% | - | - | 91.96% |
Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 12 | 11 |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 12 | 11 |
Shares Change (YoY) | - | - | - | - | 8.57% | -0.00% |
EPS (Basic) | 3.10 | 2.84 | 3.12 | 1.32 | -0.18 | 0.66 |
EPS (Diluted) | 3.10 | 2.84 | 3.12 | 1.32 | -0.18 | 0.66 |
EPS Growth | - | -8.97% | 136.36% | - | - | 92.55% |
Free Cash Flow | 2.45 | 42.59 | 20.39 | 27.79 | -24.69 | 10.47 |
Free Cash Flow Per Share | 0.21 | 3.59 | 1.72 | 2.34 | -2.08 | 0.96 |
Dividend Per Share | - | 0.750 | 0.500 | 0.128 | 0.128 | 0.064 |
Dividend Growth | - | 50.00% | 290.02% | - | 100.00% | - |
Gross Margin | 36.23% | 34.74% | 37.31% | 30.89% | 29.93% | 27.94% |
Operating Margin | 12.19% | 12.40% | 14.24% | 5.71% | 6.66% | 6.43% |
Profit Margin | 9.03% | 8.59% | 10.22% | 5.03% | -0.71% | 2.49% |
Free Cash Flow Margin | 0.60% | 10.85% | 5.62% | 8.90% | -8.25% | 3.64% |
EBITDA | 55.14 | 53.69 | 56.44 | 28.97 | 29.75 | 26.68 |
EBITDA Margin | 13.53% | 13.68% | 15.56% | 9.28% | 9.94% | 9.26% |
D&A For EBITDA | 5.49 | 5 | 4.81 | 11.13 | 9.8 | 8.15 |
EBIT | 49.65 | 48.69 | 51.63 | 17.84 | 19.95 | 18.53 |
EBIT Margin | 12.19% | 12.40% | 14.24% | 5.71% | 6.66% | 6.43% |
Effective Tax Rate | 24.75% | 25.66% | 21.55% | 21.54% | 388.89% | 31.10% |
Revenue as Reported | 415.51 | 402.68 | 369.37 | 320.29 | 307.37 | 293.06 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.